News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

Senior Vice President Sally Rosenfield Joins Women Against Alzheimer’s Network

WASHINGTON –Joining as the newest member of the Founding Board for the Women Against Alzheimer’s Network is Senior Vice President of Cure Alzheimer’s Fund, Sally Rosenfield.

Bringing together women from across the country who are leading the way in Alzheimer’s research, the Women Against Alzheimer’s Founding Network focuses on “harness[ing] the power of women” to build an “aggressive plan to prevent and treat Alzheimer’s disease.”

National Plan to Address Alzheimer's Disease

Cure Alzheimer’s Fund is grateful to President Obama for the Administration’s continued commitment to curing Alzheimer’s disease. With the implementation of the first ever National Plan To End Alzheimer’s Disease, to which Cure Alzheimer’s Fund was a contributor, and his specific targeting of the disease last night in the State of the Union address, President Obama has highlighted a national resolve to defeat this disease.

Cure Alzheimer’s Fund Receives Highest Rating from Charity Navigator

Cure Alzheimer’s Fund has been awarded the highest rating for sound fiscal management and commitment to accountability and transparency by Charity Navigator, the country’s largest and most-utilized independent evaluator of charities.

Drs. Marc Tessier-Lavigne and Robert Malenka Join Scientific Advisory Board

Cure Alzheimer's Fund (CAF) welcomes two new Scientific Advisory Board (SAB) members: Marc Tessier-Lavigne, Ph.D., president of The Rockefeller University, and former CAF Research Consortium member Robert C. Malenka, M.D., Ph.D., of Stanford University.

Featured Researcher: Giuseppina Tesco, M.D., Ph.D.

Meet Dr. Giuseppina Tesco, Cure Alzheimer’s Funded researcher, and assistant professor of neuroscience, Alzheimer’s Disease Research Laboratory, Department of Neuroscience, Tufts University School of Medicine.

Early Days

Can Venture Capital Help Cure Alzheimer's Disease?

A Pittsburgh philanthropist and retired Mellon exec thinks so. In 1988, Jeffrey L. Morby left American Express to join the management team tapped to rescue the nearly bankrupt Mellon Bank. After helping turn Mellon around, he retired at 59, but Morby has hardly been wiling away the time.

Calendars for a Cause

When Maggie Campbell’s mother-in-law, Nancy Drapeau, was diagnosed with early-onset Alzheimer’s disease last summer at age 59, Campbell decided she wanted to do something to help. Originally from Omaha, Neb., Campbell is a bookbinder and letterpress printer in Brooklyn, N.Y.

Letter from the Chairs

From our 2011 Annual Report.

 

Dear Friends,

On behalf of the Board of Directors and the Research Consortium, we want to thank all the donors, researchers and academic institutional partners supporting Cure Alzheimer’s Fund research for your help in making 2011 such a successful science year. Guided by leading scientists in the field, Cure Alzheimer’s Fund-supported research continues to make breakthrough progress toward our goal of eradicating Alzheimer’s disease.

TREM2: New candidate gene for AD

Rudy Tanzi, Chair, Cure Alzheimer's Fund Research Consortium comments here on the AP article appearing on this topic today: